On Oct. 25, Pharma Research Products (214450) declined 4.39% to 41,350 won (US$ 36.30). It had declined 19.71% through the past month. Standard deviation, the volatility index for stock price, was 1.9% over the same period of time over one month.

Compared with its close competitors within the same industry, KOSDAQ, the monthly volatility of Pharma Research Products was not so high, the earnings rate for 1 month was also the lowest with decline of stock price. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was -10.3%. As bearish stock price trend, the return-on-risk was poor, compared with its peer group. Moreover, compared with the KOSDAQ industry, the return-on-risk is below the industrial mean, -9.1, and thus it is hard to say that the industrial comparison performance was positive.